ALX Oncology Holdings Inc.
ALXO
$1.90
-$0.11-5.25%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -80.89M | -88.87M | -101.70M | -108.01M | -116.57M |
| Total Depreciation and Amortization | 1.02M | 1.17M | 1.23M | 1.29M | 1.36M |
| Total Amortization of Deferred Charges | 278.00K | 281.00K | 280.00K | 277.00K | 271.00K |
| Total Other Non-Cash Items | 9.08M | 13.24M | 15.71M | 18.40M | 22.06M |
| Change in Net Operating Assets | -261.00K | -3.95M | 336.00K | -9.16M | -12.61M |
| Cash from Operations | -70.78M | -78.13M | -84.14M | -97.21M | -105.49M |
| Capital Expenditure | -172.00K | -202.00K | -212.00K | -223.00K | -316.00K |
| Sale of Property, Plant, and Equipment | 44.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -65.76M | -49.89M | 82.80M | 104.76M | 109.15M |
| Cash from Investing | -65.89M | -50.10M | 82.59M | 104.54M | 108.84M |
| Total Debt Issued | 10.00M | -- | -- | -- | -- |
| Total Debt Repaid | -3.97M | -2.67M | -1.36M | -780.00K | -978.00K |
| Issuance of Common Stock | 150.80M | 150.71M | 38.00K | 61.00K | 594.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.58M | -8.15M | 1.69M | 731.00K | 806.00K |
| Cash from Financing | 140.25M | 139.89M | 362.00K | 12.00K | 422.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.59M | 11.67M | -1.19M | 7.34M | 3.77M |